Clinical Trial Update: Growth Hormone in Decompensated Liver Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update showing completion of Phase 2 and Phase 3 studies evaluating Growth Hormone in patients with decompensated liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Liver Cirrhosis
• Liver Fibrosis
• Sarcopenia

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Liver Cirrhosis, Fibrosis | Phase 2, Phase 3 | Status: COMPLETED